AquaBounty Technologies (LON:ABTU) has initiated field trials of its AquaAdvantage genetically modified salmon in Brazil and Argentina. 

Its genetically modified salmon have already been approved for sale in the US and Canada, the group is now seeking other markets.

"We are making the necessary preparations for the commercial launch of our product and we look forward to bringing our more sustainably produced salmon to consumers, with the assurance that it is nutritious, safe and healthy,” said chief executive Ron Stotish.
Read the full story

A collection of stories from guest authors.

Join the Conversation